
First children vaccinated in Moderna's Phase 2/3 pediatric Covid-19 vaccine trial, company says
CNN
The first children have been vaccinated in Moderna's Phase 2/3 pediatric Covid-19 vaccine trial, the company announced Tuesday in a statement.
The clinical trial, called the KidCOVE study, will enroll approximately 6,750 children in the US and Canada between the ages of 6 months and 11 years old.More Related News













